Skip to content

Micro vs. Standard Trabeculectomy Study

Micro vs. Standard Trabeculectomy Study

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02598765
Enrollment
100
Registered
2015-11-06
Start date
2016-04-04
Completion date
2020-07-21
Last updated
2026-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma

Keywords

Glaucoma, Trabeculectomy, Eye Disease, Intraocular Pressure, Visual Acuity

Brief summary

The purpose of this study is to determine the reduction in intraocular pressure and cumulative incidence of complications between the standard and micro trabeculectomy surgeries 3 months after surgery.

Detailed description

This study is a randomized, double-masked (study participants and outcome assessors) trial. During the enrollment period, consecutive patients from LEI who are planning to have trabeculectomy surgery and who meet the study enrollment criteria will be randomized to receive standard trabeculectomy or microtrabeculectomy. The primary outcome is complications and change in intraocular pressure after a 3 month follow-up period. We will perform subgroup analyses by stratifying the population according to skin pigmentation to determine whether pigmentation is a predictor of treatment success.

Interventions

PROCEDUREStandard Trabeculectomy

Fornix-based trabeculectomy with a 3x4 mm scleral flap.

PROCEDUREMicrotrabeculectomy

Fornix-based trabeculectomy with a 2x2 mm scleral flap.

Sponsors

University of California, San Francisco
Lead SponsorOTHER
Seva Foundation
CollaboratorOTHER
Lumbini Eye Institute and Research Centre
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
40 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age \>= 40 * Planning to have a trabeculectomy

Exclusion criteria

* Life threatening or debilitating disease * Inability to complete necessary exams and/or ocular disease that would preclude assessment of intraocular pressure, visual field, or optic disc * Contralateral eye already enrolled in study

Design outcomes

Primary

MeasureTime frameDescription
Cumulative incidence of complications3 months after surgeryComparison of the cumulative incidence of complications between the treatment groups (regular and micro trabeculectomy) 3 months after surgery

Secondary

MeasureTime frameDescription
Reduction in intraocular pressure3 months after surgeryComparison of the reduction in intraocular pressure between the treatment groups (regular and micro trabeculectomy) 3 months after surgery
Cumulative incidence of complications6 and 12 months after surgeryCumulative incidence of complications 6 months and 12 months after surgery will be compared between the treatment groups
Reduction of intraocular pressure6 and 12 months after surgeryReduction of intraocular pressure 6 months and 12 months after surgery will be compared between the treatment groups

Countries

Nepal

Contacts

PRINCIPAL_INVESTIGATORJeremy D Keenan, MD, MPH

F. I. Proctor Foundation, UCSF

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 2, 2026